Crowley Wealth Management, Inc. Nuvation Bio Inc. Transaction History
Crowley Wealth Management, Inc.
- $126 Billion
- Q3 2025
A detailed history of Crowley Wealth Management, Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Crowley Wealth Management, Inc. holds 106,798 shares of NUVB stock, worth $395,152. This represents 0.31% of its overall portfolio holdings.
Number of Shares
106,798
Previous 106,798
-0.0%
Holding current value
$395,152
Previous $208 Million
89.74%
% of portfolio
0.31%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding NUVB
# of Institutions
196Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$96 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$60.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$58.8 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$40.9 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$37.9 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $804M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...